Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNA interference (RNAi) is a conserved biological process in eukaryotes that regulates gene expression by using small RNA molecules to silence specific messenger RNAs (mRNAs), thereby preventing the production of particular proteins. The pathway is triggered by double-stranded RNA (dsRNA) and results in sequence-specific suppression of gene expression through either mRNA degradation or translational repression. Key components include dsRNA, Dicer, siRNAs, miRNAs, Argonaute proteins, and the RISC complex.
siRNAs or miRNAs guide RISC to target mRNAs for degradation or translational repression.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA Interference Pathway.